LYRA - Lyra Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LYRA is currently covered by 5 analysts with an average price target of $14.13. This is a potential upside of $7.84 (124.64%) from yesterday's end of day stock price of $6.29.

Lyra Therapeutics 's activity chart (see below) currently has 9 price targets and 20 ratings on display. The stock rating distribution of LYRA is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.57% with an average time for these price targets to be met of 575.17 days.

Highest price target for LYRA is $16, Lowest price target is $16, average price target is $8.83.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 14-Aug-2025. First documented stock forecast 26-May-2020.

Best performing analysts who are covering LYRA - Lyra Therapeutics :

Jason Gerberry Matthew Caufield Robert Hazlett Louise Chen Dennis Ding Justin Zelin

Currently out of the existing stock ratings of LYRA, 7 are a BUY (50%), 7 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$16

$9.71 (154.37%)

$16

30 days ago
(14-Aug-2025)

5/7 (71.43%)

$8.9 (125.35%)

422

Buy

1 years 29 days ago
(15-Aug-2024)

1/1 (100%)

$9 (150.00%)

1105

Hold

$0.5

$-5.79 (-92.05%)

1 years 4 months 6 days ago
(07-May-2024)

1/1 (100%)

$0.08 (19.05%)

386

Hold

$15

1 years 4 months 7 days ago
(06-May-2024)

1/1 (100%)

$11.36 (312.09%)

605

Buy

$10

$3.71 (58.98%)

$11

1 years 4 months 11 days ago
(02-May-2024)

6/6 (100%)

$5.37 (115.98%)

933

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LYRA (Lyra Therapeutics ) average time for price targets to be met?

On average it took 575.17 days on average for the stock forecasts to be realized with a an average price target met ratio 78.57

Which analyst has the current highest performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JASON GERBERRY

Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?

Jason Gerberry works at BAML and has 5 price targets and 3 ratings on LYRA

Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?

Matthew Caufield with highest potential upside - $9.71

Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?

Dennis Ding with lowest potential downside - -$5.79

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?